vs
Side-by-side financial comparison of FIRST MERCHANTS CORP (FRME) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.
FIRST MERCHANTS CORP is the larger business by last-quarter revenue ($157.1M vs $150.6M, roughly 1.0× GLAUKOS Corp). FIRST MERCHANTS CORP runs the higher net margin — 17.9% vs 6.2%, a 11.7% gap on every dollar of revenue. Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs -0.9%).
First Merchants Corporation is a financial holding company in Central Indiana, headquartered in Muncie, Indiana. The Corporation includes First Merchants Bank and First Merchants Private Wealth Advisors. The company is listed on the NASDAQ as FRME. As of March 2023, total asset size of First Merchants Corporation was $18.2 billion. First Merchants offers commercial banking, personal banking, and investment advisor services.
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
FRME vs GKOS — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $157.1M | $150.6M |
| Net Profit | $28.2M | $9.4M |
| Gross Margin | — | 77.9% |
| Operating Margin | — | 9.0% |
| Net Margin | 17.9% | 6.2% |
| Revenue YoY | — | 41.2% |
| Net Profit YoY | -49.1% | — |
| EPS (diluted) | $0.45 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $157.1M | $150.6M | ||
| Q4 25 | $172.2M | $143.1M | ||
| Q3 25 | $166.1M | $133.5M | ||
| Q2 25 | $164.3M | $124.1M | ||
| Q1 25 | $160.3M | $106.7M | ||
| Q4 24 | $177.1M | $105.5M | ||
| Q3 24 | $156.0M | $96.7M | ||
| Q2 24 | $159.9M | $95.7M |
| Q1 26 | $28.2M | $9.4M | ||
| Q4 25 | $57.1M | $-133.7M | ||
| Q3 25 | $56.8M | $-16.2M | ||
| Q2 25 | $56.8M | $-19.7M | ||
| Q1 25 | $55.3M | $-18.1M | ||
| Q4 24 | $64.3M | $-33.6M | ||
| Q3 24 | $49.2M | $-21.4M | ||
| Q2 24 | $39.9M | $-50.5M |
| Q1 26 | — | 77.9% | ||
| Q4 25 | — | -1.1% | ||
| Q3 25 | — | 78.4% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 77.2% | ||
| Q4 24 | — | 72.9% | ||
| Q3 24 | — | 76.6% | ||
| Q2 24 | — | 76.4% |
| Q1 26 | — | 9.0% | ||
| Q4 25 | 38.0% | -97.7% | ||
| Q3 25 | 39.3% | -12.3% | ||
| Q2 25 | 39.6% | -18.3% | ||
| Q1 25 | 39.4% | -19.4% | ||
| Q4 24 | 43.3% | -27.2% | ||
| Q3 24 | 36.1% | -25.5% | ||
| Q2 24 | 27.5% | -31.3% |
| Q1 26 | 17.9% | 6.2% | ||
| Q4 25 | 33.1% | -93.4% | ||
| Q3 25 | 34.2% | -12.2% | ||
| Q2 25 | 34.6% | -15.8% | ||
| Q1 25 | 34.5% | -17.0% | ||
| Q4 24 | 36.3% | -31.8% | ||
| Q3 24 | 31.5% | -22.1% | ||
| Q2 24 | 25.0% | -52.8% |
| Q1 26 | $0.45 | — | ||
| Q4 25 | $0.98 | $-2.34 | ||
| Q3 25 | $0.98 | $-0.28 | ||
| Q2 25 | $0.98 | $-0.34 | ||
| Q1 25 | $0.94 | $-0.32 | ||
| Q4 24 | $1.09 | $-0.56 | ||
| Q3 24 | $0.84 | $-0.39 | ||
| Q2 24 | $0.68 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $276.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $670.9M |
| Total Assets | $21.1B | $893.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $276.7M | ||
| Q4 25 | — | $90.8M | ||
| Q3 25 | — | $98.2M | ||
| Q2 25 | — | $100.8M | ||
| Q1 25 | — | $114.3M | ||
| Q4 24 | — | $169.6M | ||
| Q3 24 | — | $100.1M | ||
| Q2 24 | — | $68.1M |
| Q1 26 | $2.7B | $670.9M | ||
| Q4 25 | $2.5B | $656.2M | ||
| Q3 25 | $2.4B | $769.5M | ||
| Q2 25 | $2.3B | $765.1M | ||
| Q1 25 | $2.3B | $764.0M | ||
| Q4 24 | $2.3B | $766.9M | ||
| Q3 24 | $2.3B | $668.5M | ||
| Q2 24 | $2.2B | $665.2M |
| Q1 26 | $21.1B | $893.3M | ||
| Q4 25 | $19.0B | $893.5M | ||
| Q3 25 | $18.8B | $999.4M | ||
| Q2 25 | $18.6B | $987.0M | ||
| Q1 25 | $18.4B | $966.2M | ||
| Q4 24 | $18.3B | $974.8M | ||
| Q3 24 | $18.3B | $926.5M | ||
| Q2 24 | $18.3B | $919.7M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRME
| Net Interest Income | $151.3M | 96% |
| Noninterest Income | $5.8M | 4% |
GKOS
Segment breakdown not available.
